Searched for
VACCINE OPTION
'Don't die in the meantime': Millionaire Bryan Johnson says some humans may live forever, shares three reasons whyLongevity advocate Bryan Johnson predicts a future where humans might live indefinitely, driven by rapid advancements in biotech and AI. He...- Germany student health insurance guide: Eligibility, costs and coverageGermany mandates health insurance for all international students seeking university admission. Students can choose between public or privat...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- New pet at home? Here’s why pet insurance should be your first move, not an afterthoughtGetting a new pet is exciting but also costly and risky. Many owners forget to buy pet insurance early, which can lead to problems later. V...
- Novavax awaits FDA decision on whether its next COVID shot can be offered in USNovavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator tol...
- Johnson & Johnson suspends Covid vaccine sales forecastVaccine options from rival drugmakers Pfizer and Moderna have been much more commonly used so far in the United States, where overall vacci...
- Children aged 12-14 may get more vaccination optionsPeople in the government are hopeful that by the time vaccination starts for this age group, results of clinical trials of Covovax and Corb...
- Covaxin only vaccine option for children in 15-18 years age group due to new guidelinesOn vaccination of children, the guidelines said, "For such beneficiaries, option for vaccination would only be available for Covaxin as thi...
- US CDC recommends Pfizer, Moderna COVID-19 shots over J&J'sUntil now the U.S. has treated all three COVID-19 vaccines available to Americans as an equal choice, since large studies found they all of...
- More vaccinated Indians are looking to book flights to Europe after quarantine waiverLast week, Austria, Estonia, Germany, Greece, Ireland, the Netherlands, Slovenia, Spain, Switzerland and Iceland announced quarantine waive...
- Japan Olympic adviser urges COVID-19 vaccine option for athletesJapan on Thursday had dismissed a media report that it was considering vaccinating all its Olympians by the end of June after the idea spar...
- India seeks funds from Quad alliance to match China's vaccine push-sourceBeijing has committed to provide at least 463 million doses of its home-made COVID-19 vaccines through exports and donations across the wor...
- Phase 2 of Covid vaccination: People with comorbidities will need medical certificate to get the jabThere are currently two vaccines in use in India – Covishield, the AstraZeneca/Oxford vaccine made by of Serum Institute of India, and Bhar...
- USFDA says single-dose shot from J&J prevents severe COVIDFood and Drug Administration scientists on Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to se...
- FDA says J&J single-dose shot prevents COVID; final decision soonThat's just one step in the FDA's evaluation of a third vaccine option for the U.S. On Friday, the agency's independent advisers will debat...
- Volunteers still needed to test variety of COVID-19 vaccinesModerna Inc. and competitor Pfizer Inc. recently announced preliminary results showing their vaccines appear more than 90% effective, at le...
- World Health Organization sweetens terms to join struggling global COVAX vaccine facilityThe change appears aimed at convincing governments which have negotiated their own bilateral deals securing experimental vaccines to also s...
Load More
